Literature DB >> 31191204

Combined Phenotypes of Spondylometaphyseal Dysplasia-Kozlowski Type and Charcot-Marie-Tooth Disease Type 2C Secondary to a TRPV4 Pathogenic Variant.

Eden Faye1, Peggy Modaff1, Richard Pauli1, Janet Legare1.   

Abstract

TRPV4, a nonselective calcium permeable ion channel, is expressed broadly in many organs including bone and neurons. Pathogenic variants in TRPV4 are known to cause both a spectrum of skeletal dysplasias and neuropathies. Recent publications have documented a few patients who have a combined phenotype of skeletal dysplasia and neuropathy secondary to TRPV4 pathogenic variants. We present an additional patient who has an overlapping neuromuscular and skeletal phenotype secondary to a TRPV4 pathogenic variant. The patient has spondylometaphyseal dysplasia-Kozlowski type and Charcot-Marie-Tooth disease type 2C. This and prior reports illustrate that TRPV4-related skeletal dysplasias and TRPV4-related neuropathies are not fully distinct disorders secondary to unique sets of pathogenic variants as originally postulated, but rather are 2 phenotypes on the same spectrum that may or may not overlap. We suggest that evaluation for patients presenting with any TRPV4-related disorder include assessment for both skeletal and neurological findings.

Entities:  

Keywords:  CMT2C; Charcot-Marie-Tooth; SMD-K; Spondlyometaphyseal dysplasia Kozlowski; TRPV4

Year:  2018        PMID: 31191204      PMCID: PMC6528083          DOI: 10.1159/000495778

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  21 in total

Review 1.  Transient receptor potential vanilloid 4: The sixth sense of the musculoskeletal system?

Authors:  Farshid Guilak; Holly A Leddy; Wolfgang Liedtke
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

2.  Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.

Authors:  Magdalena Zimoń; Jonathan Baets; Michaela Auer-Grumbach; José Berciano; Antonio Garcia; Eduardo Lopez-Laso; Luciano Merlini; David Hilton-Jones; Meriel McEntagart; Andrew H Crosby; Nina Barisic; Eugen Boltshauser; Christopher E Shaw; Guida Landouré; Christy L Ludlow; Rachelle Gaudet; Henry Houlden; Mary M Reilly; Kenneth H Fischbeck; Charlotte J Sumner; Vincent Timmerman; Albena Jordanova; Peter De Jonghe
Journal:  Brain       Date:  2010-05-11       Impact factor: 13.501

3.  Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia.

Authors:  Deborah Krakow; Joris Vriens; Natalia Camacho; Phi Luong; Hannah Deixler; Tara L Funari; Carlos A Bacino; Mira B Irons; Ingrid A Holm; Laurie Sadler; Ericka B Okenfuss; Annelies Janssens; Thomas Voets; David L Rimoin; Ralph S Lachman; Bernd Nilius; Daniel H Cohn
Journal:  Am J Hum Genet       Date:  2009-02-19       Impact factor: 11.025

Review 4.  The vanilloid transient receptor potential channel TRPV4: from structure to disease.

Authors:  Wouter Everaerts; Bernd Nilius; Grzegorz Owsianik
Journal:  Prog Biophys Mol Biol       Date:  2009-10-14       Impact factor: 3.667

5.  Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.

Authors:  Matthew J Rock; Jean Prenen; Vincent A Funari; Tara L Funari; Barry Merriman; Stanley F Nelson; Ralph S Lachman; William R Wilcox; Soraya Reyno; Roberto Quadrelli; Alicia Vaglio; Grzegorz Owsianik; Annelies Janssens; Thomas Voets; Shiro Ikegawa; Toshiro Nagai; David L Rimoin; Bernd Nilius; Daniel H Cohn
Journal:  Nat Genet       Date:  2008-06-29       Impact factor: 38.330

6.  TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts.

Authors:  Ritsuko Masuyama; Joris Vriens; Thomas Voets; Yuji Karashima; Grzegorz Owsianik; Rudi Vennekens; Liesbet Lieben; Sophie Torrekens; Karen Moermans; An Vanden Bosch; Roger Bouillon; Bernd Nilius; Geert Carmeliet
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

7.  Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation.

Authors:  Shuji Muramatsu; Makoto Wakabayashi; Takeshi Ohno; Katsuhiko Amano; Rika Ooishi; Toshinori Sugahara; Satoshi Shiojiri; Kosuke Tashiro; Yutaka Suzuki; Riko Nishimura; Satoru Kuhara; Sumio Sugano; Toshiyuki Yoneda; Akio Matsuda
Journal:  J Biol Chem       Date:  2007-09-05       Impact factor: 5.157

8.  Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.

Authors:  Michaela Auer-Grumbach; Andrea Olschewski; Lea Papić; Hannie Kremer; Meriel E McEntagart; Sabine Uhrig; Carina Fischer; Eleonore Fröhlich; Zoltán Bálint; Bi Tang; Heimo Strohmaier; Hanns Lochmüller; Beate Schlotter-Weigel; Jan Senderek; Angelika Krebs; Katherine J Dick; Richard Petty; Cheryl Longman; Neil E Anderson; George W Padberg; Helenius J Schelhaas; Conny M A van Ravenswaaij-Arts; Thomas R Pieber; Andrew H Crosby; Christian Guelly
Journal:  Nat Genet       Date:  2009-12-27       Impact factor: 38.330

9.  Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.

Authors:  Han-Xiang Deng; Christopher J Klein; Jianhua Yan; Yong Shi; Yanhong Wu; Faisal Fecto; Hau-Jie Yau; Yi Yang; Hong Zhai; Nailah Siddique; E Tessa Hedley-Whyte; Robert Delong; Marco Martina; Peter J Dyck; Teepu Siddique
Journal:  Nat Genet       Date:  2009-12-27       Impact factor: 38.330

10.  Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.

Authors:  Guida Landouré; Anselm A Zdebik; Tara L Martinez; Barrington G Burnett; Horia C Stanescu; Hitoshi Inada; Yijun Shi; Addis A Taye; Lingling Kong; Clare H Munns; Shelly S Choo; Christopher B Phelps; Reema Paudel; Henry Houlden; Christy L Ludlow; Michael J Caterina; Rachelle Gaudet; Robert Kleta; Kenneth H Fischbeck; Charlotte J Sumner
Journal:  Nat Genet       Date:  2009-12-27       Impact factor: 38.330

View more
  4 in total

1.  Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension.

Authors:  Brett A McCray; Erika Diehl; Jeremy M Sullivan; William H Aisenberg; Nicholas W Zaccor; Alexander R Lau; Dominick J Rich; Benedikt Goretzki; Ute A Hellmich; Thomas E Lloyd; Charlotte J Sumner
Journal:  Nat Commun       Date:  2021-03-04       Impact factor: 14.919

2.  TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.

Authors:  Arens Taga; Margo A Peyton; Benedikt Goretzki; Thomas Q Gallagher; Ann Ritter; Amy Harper; Thomas O Crawford; Ute A Hellmich; Charlotte J Sumner; Brett A McCray
Journal:  Ann Clin Transl Neurol       Date:  2022-02-16       Impact factor: 4.511

3.  Exploring and expanding the phenotype and genotype diversity in seven Chinese families with spondylo-epi-metaphyseal dysplasia.

Authors:  Shanshan Lv; Jiao Zhao; Li Liu; Chun Wang; Hua Yue; Hao Zhang; Shanshan Li; Zhenlin Zhang
Journal:  Front Genet       Date:  2022-08-31       Impact factor: 4.772

Review 4.  Transient Receptor Potential Vanilloid in the Brain Gliovascular Unit: Prospective Targets in Therapy.

Authors:  Huilong Luo; Xavier Declèves; Salvatore Cisternino
Journal:  Pharmaceutics       Date:  2021-03-04       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.